Loading
Obesity · Journal article
Talanta · June 26, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a preclinical animal study demonstrating that oral Bambusa balcooa leaf extract reduced body weight, improved glucose and lipid profiles, and decreased adipose tissue oxidative stress markers in high-fat diet-fed mice. The work is mechanistic and hypothesis-generating; it does not provide evidence for clinical efficacy in humans and should not inform clinical practice without human trial data.
Animal study (in vivo, murine model). C57BL/6 mice with high-fat diet-induced obesity.. Intervention: Bambusa balcooa leaf extract (BLE) 200 mg/kg body weight, oral, for 70 days.
BLE at 200 mg/kg significantly reduced body and organ weights in HFD-induced obese mice Blood glucose levels and lipid profiles were improved in the HFD + BL group LDH and LPO levels were significantly decreased in adipose tissue of treated mice
No dose-response or safety data provided; long-term effects in humans not examined.
This study provides no direct clinical guidance. Professionals should regard this as early mechanistic work identifying potential bioactive constituents; human trials would be required before any therapeutic recommendation could be considered.
Single animal study with surrogate endpoints (biochemical markers and histology) in mice; no human data, no clinical outcomes, and no comparator group explicitly stated.
As stated by the source record.
Quoted from the source exactly as published.
This study provides no direct clinical guidance. Professionals should regard this as early mechanistic work identifying potential bioactive constituents; human trials would be required before any therapeutic recommendation could be considered.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
The ameliorative potential of Bambusa balcooa leaf extract against high-fat diet (HFD) metabolic dysregulation and oxidative stress was evaluated in C57BL/6 mouse adipocytes. Oral administration of Bambusa balcooa leaf extract (BLE; 200 mg/kg b.w.) for 70 days significantly reduced body and organ weights in HFD-induced obese mice while improving blood glucose levels and lipid profiles. In the adipose tissue of the HFD + BL group, lactate dehydrogenase (LDH) and lipid peroxidation (LPO) levels were significantly decreased, accompanied by enhanced endogenous antioxidant defenses and reduced oxidative stress. Furthermore, HFD-induced histological alterations in adipose tissue were markedly restored, confirming the protective role of BLE. Structural and chemical characterization via UV-Vis, FTIR, and GC-MS analyses identified 37 bioactive compounds. Among these, phytol, γ sitosterol, campesterol, neophytadiene, N,N-dimethylglycine, dl-α-tocopherol, phenol 3,5-bis(1,1-dimethylethyl)-, squalene, and octacosanol were identified as the major bioactive agents. These findings demonstrate that B. balcooa leaf extract exhibits strong protective potential for managing HFD-induced obesity-linked metabolic dysregulation and adipocyte oxidative stress.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.